Responding to the government's calls for epidemic prevention and control, Beijing China-Germany Industrial Park has been trying to seek a balance in epidemic prevention and corporate services. On one hand, it has been requiring working at home to reduce mobility. On the other hand, the industrial park has hold online meetings for investment attraction and project docking to ensure normal business operations.
The Beijing China-Germany Industrial Park recently held an online project docking meeting for the latest landing project with LE SURMOI to accelerate the construction of international clinical trial research platform by opening up all links. Relevant companies and institutions in Shunyi district attended the meeting.
At the meeting, the industrial park gave a detailed introduction of the overall situation, the latest work progress and the significance of the project "LE SURMOI International Clinical Trial Research Platform". Zhang Chu, managing director of LE SURMOI Life Technology Industry Holding Group (referred to as LE SURMOI), talked about the global development trend of the life science and technology industry, the leading position of the project in the industry and the company's existing business layout and planning. LE SURMOI has signed a contract to land on the fifth floor of China-Germany Plaza at the industrial park, and started the platform company registration process. According to Zhang, the company plans to carry out clinical trial research and professional training services in the park, including setting up a research platform and a clinical research operation center, a clinical trial research center, and provide clinical research GCP training and certification services.
The Beijing China-Germany Industrial Park has been cultivating a medical and health industry ecology, and promoting the gathering of high-precision medical and health enterprises. The industrial park will take the construction of "LE SURMOI International Clinical Trial Research Platform" as an opportunity to attract upstream and downstream companies in the industrial chain, and boost the development of the medical industry in the park. The industrial park will carefully listen to the demands of enterprises, innovate policies and measures to help enterprises improve quality and efficiency.
About LE SURMOI Life Technology Industry Holding Group
LE SURMO has a number of top academicians and authoritative experts in the field of life science and artificial intelligence computing in Germany, Europe and China, and has close collaboration with professors, doctoral students and postgraduate students from first-class scientific research institutions in China. It is very forward-looking digital life science group driven by dual technology engines of life science and artificial intelligence computing. The company is committed to building a core institution for innovative pharmaceutical clinical research and a public service platform that conform to international norms and technical standards, so as to standardize clinical research, especially cell therapy.
